Novocure
NVCR
#5392
Rank
โ‚น121.82 B
Marketcap
Country
โ‚น1,088
Share price
2.98%
Change (1 day)
-54.04%
Change (1 year)
Categories

Revenue for Novocure (NVCR)

Revenue in 2025 (TTM): โ‚น55.54 Billion

According to Novocure 's latest financial reports the company's current revenue (TTM ) is โ‚น57.69 Billion. In 2024 the company made a revenue of โ‚น51.91 Billion an increase over the revenue in the year 2023 that were of โ‚น42.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novocure from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น55.54 B6.99%
2024 โ‚น51.91 B22.45%
2023 โ‚น42.40 B-4.73%
2022 โ‚น44.50 B11.76%
2021 โ‚น39.82 B10.15%
2020 โ‚น36.15 B44.31%
2019 โ‚น25.05 B44.43%
2018 โ‚น17.34 B53.46%
2017 โ‚น11.30 B100.67%
2016 โ‚น5.63 B156.17%
2015 โ‚น2.19 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
โ‚น57.69 B 0.00% Jersey
Novavax
NVAX
โ‚น92.02 B 59.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
โ‚น12.93 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น1.96 B-96.60%๐Ÿ‡ฌ๐Ÿ‡ง UK